NDC 64406-102

Aduhelm

Aducanumab

Aduhelm is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Biogen Inc.. The primary component is Aducanumab.

Product ID64406-102_389fccbc-5f19-4f85-bd4c-e6160a45b242
NDC64406-102
Product TypeHuman Prescription Drug
Proprietary NameAduhelm
Generic NameAducanumab
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-06-07
Marketing CategoryBLA /
Application NumberBLA761178
Labeler NameBiogen Inc.
Substance NameADUCANUMAB
Active Ingredient Strength100 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 64406-102-02

1 VIAL in 1 CARTON (64406-102-02) > 3 mL in 1 VIAL
Marketing Start Date2021-06-07
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Aduhelm" or generic name "Aducanumab"

NDCBrand NameGeneric Name
64406-101AduhelmAducanumab
64406-102AduhelmAducanumab

Trademark Results [Aduhelm]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ADUHELM
ADUHELM
90709506 not registered Live/Pending
Biogen MA Inc.
2021-05-13
ADUHELM
ADUHELM
88841987 not registered Live/Pending
Biogen MA Inc.
2020-03-20
ADUHELM
ADUHELM
87840337 not registered Live/Pending
Biogen MA, Inc.
2018-03-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.